Haemonetics Corp (HAE)

Haemonetics Corp Azioni (HAE) Dati Finanziari

Conto economico

Trimestrale

*Tutti i numeri sono espressi in milioni

Data di fine periodo	2024-03-30	2023-12-30	2023-09-30	2023-07-01	2023-04-01
Durata del periodo	3 mesi	3 mesi	3 mesi	3 mesi	3 mesi
Revenues	2.09% 343.29	336.25	318.18	311.33	304.42
Cost Of Revenue	5.68% 167.38	158.38	147.67	144.07	148.17
Gross Profit	1.10% 175.91	177.87	170.51	167.26	156.25
Operating Expenses	10.67% 145.96	131.89	135.21	113.61	120.99
Benefits Costs and Expenses	9.46% 319.88	292.22	285.35	259.74	271.79
Costs And Expenses	9.46% 319.88	292.22	285.35	259.74	271.79
Depreciation and Amortization	17.46% 27.64	23.53	23.01	23.03	23.85
Operating Income/Loss	34.88% 29.94	45.98	35.30	53.66	35.26
Income/Loss From Continuing Operations Before Tax	46.82% 23.41	44.03	32.83	51.59	32.63
Income Tax Expense/Benefit	76.17% 3.047	12.79	7.924	10.55	3.243
Income/Loss From Continuing Operations After Tax	34.81% 20.37	31.24	24.91	41.04	29.38
Net Income/Loss	34.81% 20.37	31.24	24.91	41.04	29.38
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	99.95% 0.027	50.77	50.73	50.54	-0.113
Diluted Average Shares	99.99% 0.003	51.45	51.40	51.34	-0.067
Basic Earnings Per Share	35.48% 0.40	0.62	0.49	0.81	0.58
Diluted Earnings Per Share	34.43% 0.40	0.61	0.48	0.80	0.57
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-